Your request to link to rcsb for HIF-1alpha-PHD2

• 2G19: cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (phd2) (10.1073/PNAS.0601283103 )
• 2G1M: cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (phd2) (10.1073/PNAS.0601283103 )
• 2HBT: crystal structure of hif prolyl hydroxylase egln-1 in complex with a biologically active inhibitor
• 2HBU: crystal structure of hif prolyl hydroxylase egln-1 in complex with a biologically active inhibitor
• 2Y33: s-nitrosylated phd2 (gsno soaked) in complex with zn(ii) and un9 (10.1016/J.JMB.2011.04.075 )
• 2Y34: s-nitrosylated phd2 (no exposed) in complex with fe(ii) and un9 (10.1016/J.JMB.2011.04.075 )
• 3HQR: phd2:mn:nog:hif1-alpha substrate complex (10.1016/J.STR.2009.06.002 )
• 3HQU: phd2:fe:un9:partial hif1-alpha substrate complex (10.1016/J.STR.2009.06.002 )
• 3OUH: phd2-r127 with jnj41536014 (10.1021/ML100198Y )
• 3OUI: phd2-r717 with 40787422 (10.1021/ML100198Y )
• 3OUJ: phd2 with 2-oxoglutarate (10.1021/ML100198Y )
• 4BQW: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with mn(ii) and 2- (4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid (10.1021/CB400088Q )
• 4BQX: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with mn(ii) and n- [(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) (10.1021/CB400088Q )
• 4BQY: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with fe(ii) and n- [(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]alanine (10.1021/CB400088Q )
• 4JZR: structure of prolyl hydroxylase domain-containing protein (phd) with inhibitors (10.1016/J.BMC.2013.08.046 )
• 4KBZ: crystal structure of hypoxia-inducible factor prolyl hydroxylase (phd2) with (s)-{2-[2-(5-cyano-3-hydroxy-pyridin-2-yl)-thiazol-4-yl]- acetylamino}-phenyl-acetic acid
• 4UWD: hif prolyl hydroxylase 2 (phd2/ egln1) d315e variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) (10.1042/BJ20140779 )
• 5A3U: hif prolyl hydroxylase 2 (phd2/egln1) in complex with 6-(5-oxo-4-(1h- 1,2,3-triazol-1-yl)-2,5-dihydro-1h-pyrazol-1-yl)nicotinic acid (10.1371/JOURNAL.PONE.0132004 )
• 5L9B: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with 2-oxoglutarate (2og) and hif-1alpha codd (556-574) (10.1038/NCOMMS12673 )
• 5L9R: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with n-oxalylglycine (nog) (10.1038/NCOMMS12673 )
• 5L9V: hif prolyl hydroxylase 2 (phd2-r281c/p317c) cross-linked to hif-1alpha nodd-l397c/d412c and n-oxalylglycine (nog) (complex-1) (10.1038/NCOMMS12673 )
• 5LA9: hif prolyl hydroxylase 2 (phd2-r281c/v314c) cross-linked to hif-1alpha nodd-l397c/d412c and n-oxalylglycine (nog) (complex-2) (10.1038/NCOMMS12673 )
• 5LAS: hif prolyl hydroxylase 2 (phd2-r281c/p317c/r396t) cross-linked to hif- 1alpha nodd-l397c/d412c and n-oxalylglycine (nog) (complex-3) (10.1038/NCOMMS12673 )
• 5LAT: hif prolyl hydroxylase 2 (phd2/egln1) p317r variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) (10.1038/NCOMMS12673 )
• 5LB6: hif prolyl hydroxylase 2 (phd2/egln1) r371h variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) (10.1038/NCOMMS12673 )
• 5LBB: hif prolyl hydroxylase 2 (phd2/egln1) r396t variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/un9) (10.1038/NCOMMS12673 )
• 5LBC: hif prolyl hydroxylase 2 (phd2/egln1) i280v/r281l/i292v variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl) carbonyl]glycine (iox3/fg2216) (10.1038/NCOMMS12673 )
• 5LBE: hif prolyl hydroxylase 2 (phd2/egln1) g294e variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (iox3/fg2216) (10.1038/NCOMMS12673 )
• 5LBF: hif prolyl hydroxylase 2 (phd2/egln1) k293k/g294e variant in complex with mn(ii) and n-[(1-chloro-4-hydroxyisoquinolin-3-yl) carbonyl]glycine (iox3/fg2216) (10.1038/NCOMMS12673 )
• 5OX5: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with cct6, a gsk1278863-related compound (10.1039/C7SC02103H )
• 5OX6: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with vadadustat (10.1039/C7SC02103H )
• 5V18: structure of phd2 in complex with 1,2,4-triazolo-[1,5-a]pyridine (10.1021/ACS.JMEDCHEM.7B00352 )
• 6NMQ: hypoxia-inducible factor (hif) prolyl hydroxylase 2 (phd2) in complex with the carboxamide analog jnj43058171 (10.1021/ACSOMEGA.9B00199 )
• 6QGV: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with a spiro[4.5]decanone inhibitor (jphm-2-167) (10.1039/C8MD00548F )
• 6ST3: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with 4-hydroxy-n-(4- phenoxybenzyl)-2-(1h-pyrazol-1-yl)pyrimidine-5-carboxamide (10.1002/CMDC.201900557 )
• 6YVT: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with md-253 (10.1002/ANIE.201202000 )
• 6YVW: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with monocyclic bb- 328 (10.1038/S41598-020-76307-8 )
• 6YVX: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with bicyclic bb-287 (10.1038/S41598-020-76307-8 )
• 6YVZ: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with bicyclic jls- 367 (10.1038/S41598-020-76307-8 )
• 6YW0: lysine-n,n-dimethylated hif prolyl hydroxylase 2 (phd2/ egln1) in complex with bb-287 (10.1038/S41598-020-76307-8 )
• 6YW1: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with 2og and rapid- derived silent allosteric cyclic peptide 3c (14-mer) (10.1038/S41598-020-76307-8 )
• 6YW2: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with bicyclic fg2216 and rapid-derived cyclic peptide 3c (14-mer) (10.1038/S41598-020-76307-8 )
• 6YW3: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with n-oxalyl glycine (nog), hif-1alpha codd (556-574) and a rapid-derived cyclic peptide 3c (14-mer) (10.1038/S41598-020-76307-8 )
• 6YW4: hif prolyl hydroxylase 2 (phd2/ egln1) in complex with n-oxalylglycine (nog) and a rapid-derived silent allosteric cyclic peptide 3c (14- mer) (10.1038/S41598-020-76307-8 )
• 6ZBN: hif prolyl hydroxylase 2 (phd2/egln1) in complex with tert-butyl 6-(5- hydroxy-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-1-yl)nicotinate (iox4) (10.1002/CMDC.202100133 )
• 6ZBO: hif prolyl hydroxylase 2 (phd2/egln1) in complex with 1-(6- morpholinopyrimidin-4-yl)-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-ol (molidustat) (10.1002/CMDC.202100133 )